These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
309 related items for PubMed ID: 11226303
1. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. Kishimoto I, Rossi K, Garbers DL. Proc Natl Acad Sci U S A; 2001 Feb 27; 98(5):2703-6. PubMed ID: 11226303 [Abstract] [Full Text] [Related]
2. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A. Holtwick R, van Eickels M, Skryabin BV, Baba HA, Bubikat A, Begrow F, Schneider MD, Garbers DL, Kuhn M. J Clin Invest; 2003 May 27; 111(9):1399-407. PubMed ID: 12727932 [Abstract] [Full Text] [Related]
3. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart. Kinoshita H, Kuwahara K, Nishida M, Jian Z, Rong X, Kiyonaka S, Kuwabara Y, Kurose H, Inoue R, Mori Y, Li Y, Nakagawa Y, Usami S, Fujiwara M, Yamada Y, Minami T, Ueshima K, Nakao K. Circ Res; 2010 Jun 25; 106(12):1849-60. PubMed ID: 20448219 [Abstract] [Full Text] [Related]
4. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure. Kuhn M, Voss M, Mitko D, Stypmann J, Schmid C, Kawaguchi N, Grabellus F, Baba HA. Cardiovasc Res; 2004 Nov 01; 64(2):308-14. PubMed ID: 15485690 [Abstract] [Full Text] [Related]
5. Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart. Tokudome T, Kishimoto I, Horio T, Arai Y, Schwenke DO, Hino J, Okano I, Kawano Y, Kohno M, Miyazato M, Nakao K, Kangawa K. Circulation; 2008 May 06; 117(18):2329-39. PubMed ID: 18443239 [Abstract] [Full Text] [Related]
6. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides. Tokudome T, Horio T, Kishimoto I, Soeki T, Mori K, Kawano Y, Kohno M, Garbers DL, Nakao K, Kangawa K. Circulation; 2005 Jun 14; 111(23):3095-104. PubMed ID: 15939815 [Abstract] [Full Text] [Related]
7. Ventricular arrhythmias, increased cardiac calmodulin kinase II expression, and altered repolarization kinetics in ANP receptor deficient mice. Kirchhof P, Fabritz L, Kilić A, Begrow F, Breithardt G, Kuhn M. J Mol Cell Cardiol; 2004 May 14; 36(5):691-700. PubMed ID: 15135664 [Abstract] [Full Text] [Related]
8. Cardiac and intestinal natriuretic peptides: insights from genetically modified mice. Kuhn M. Peptides; 2005 Jun 14; 26(6):1078-85. PubMed ID: 15911075 [Abstract] [Full Text] [Related]
9. Enhanced activity of the myocardial Na+/H+ exchanger NHE-1 contributes to cardiac remodeling in atrial natriuretic peptide receptor-deficient mice. Kilic A, Velic A, De Windt LJ, Fabritz L, Voss M, Mitko D, Zwiener M, Baba HA, van Eickels M, Schlatter E, Kuhn M. Circulation; 2005 Oct 11; 112(15):2307-17. PubMed ID: 16216978 [Abstract] [Full Text] [Related]
11. Heart specific up-regulation of genes for B-type and C-type natriuretic peptide receptors in diabetic mice. Christoffersen C, Bartels ED, Nielsen LB. Eur J Clin Invest; 2006 Feb 11; 36(2):69-75. PubMed ID: 16436087 [Abstract] [Full Text] [Related]
12. Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Lopez MJ, Wong SK, Kishimoto I, Dubois S, Mach V, Friesen J, Garbers DL, Beuve A. Nature; 1995 Nov 02; 378(6552):65-8. PubMed ID: 7477288 [Abstract] [Full Text] [Related]
13. Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene. Nishikimi T, Hagaman JR, Takahashi N, Kim HS, Matsuoka H, Smithies O, Maeda N. Cardiovasc Res; 2005 Apr 01; 66(1):94-103. PubMed ID: 15769452 [Abstract] [Full Text] [Related]
14. Estrogen protects against the development of salt-induced cardiac hypertrophy in heterozygous proANP gene-disrupted mice. Sangaralingham SJ, Tse MY, Pang SC. J Endocrinol; 2007 Jul 01; 194(1):143-52. PubMed ID: 17592028 [Abstract] [Full Text] [Related]
15. Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart. Ogawa Y, Tamura N, Chusho H, Nakao K. Can J Physiol Pharmacol; 2001 Aug 01; 79(8):723-9. PubMed ID: 11558681 [Abstract] [Full Text] [Related]
16. B-type natriuretic peptide: a myocyte-specific marker for characterizing load-induced alterations in cardiac gene expression. Magga J, Vuolteenaho O, Tokola H, Marttila M, Ruskoaho H. Ann Med; 1998 Aug 01; 30 Suppl 1():39-45. PubMed ID: 9800882 [Abstract] [Full Text] [Related]
17. Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A. Kuhn M. Circ Res; 2003 Oct 17; 93(8):700-9. PubMed ID: 14563709 [Abstract] [Full Text] [Related]
18. [Cardiovascular significance of the natriuretic peptide receptor, guanylyl cyclase-A, from studies using genetically engineered mice]. Kishimoto I. Nihon Rinsho; 2004 Sep 17; 62 Suppl 9():38-42. PubMed ID: 15506333 [No Abstract] [Full Text] [Related]
19. C-type natriuretic peptide and guanylyl cyclase B receptor. Schulz S. Peptides; 2005 Jun 17; 26(6):1024-34. PubMed ID: 15911070 [Abstract] [Full Text] [Related]
20. Diverging vasorelaxing effects of C-type natriuretic peptide in renal resistance arteries and aortas of GC-A-deficient mice. Steinmetz M, Potthast R, Sabrane K, Kuhn M. Regul Pept; 2004 Jun 15; 119(1-2):31-7. PubMed ID: 15093694 [Abstract] [Full Text] [Related] Page: [Next] [New Search]